Financial statements Biocont Polska
Balance sheet data of BIOCONT POLSKA
|
Year
|
2018
|
2020
|
2021
|
|---|---|---|---|
| Total assets | 1 310 830,27 | 2 223 103,73 | 4 903 785,53 |
| A. Fixed assets | 41 004,57 | 50 993,27 | 64 245,61 |
| B. Current assets | 1 269 825,70 | 2 172 110,46 | 4 839 539,92 |
| C. Share capital contributions (basic funds) | - | - | - |
| D. Own shares (stocks) | - | - | - |
| Total liabilities | 1 310 830,27 | 2 223 103,73 | 4 903 785,53 |
| A. Equity | 960 056,24 | 1 784 698,32 | 4 000 723,54 |
| B. Liabilities and provisions for liabilities | 350 774,03 | 438 405,41 | 903 061,99 |
| I. Long-term liabilities | 241 403,95 | 172 427,63 | 103 451,31 |
| II. Short-term liabilities | 109 370,08 | 265 977,78 | 799 610,68 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.